🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy and safety adebrelimab in Combination with chemoth...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-05-19
Trial ID
NCT06424899
Treatments Being Tested
Pancreatic cancer is a highly malignant digestive system tumor with a very ...
Status
Recruiting
Location
Ningbo Medical Center Lihuili Hospital
Start Date
2025-03-25
Trial ID
NCT07542002
Treatments Being Tested
Evaluating the efficacy and safety of PD-L1 (Programmed Death-L1)antibody c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10
Trial ID
NCT06599775
Treatments Being Tested
This is a single-arm, prospective, exploratory phase II clinical study. The...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-06-21
Trial ID
NCT06483282
Treatments Being Tested
Prospective single-arm clinical study of adebrelimab combined with concurre...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-01
Trial ID
NCT06149767
Treatments Being Tested
To evaluate the efficacy, safety and organ retention rate of short-course r...
Status
Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Start Date
2024-01-01
Trial ID
NCT06266832
Treatments Being Tested
This is a multicenter, cohort, prospective study to evaluate the efficacy a...
Status
Recruiting
Location
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Start Date
2025-09-12
Trial ID
NCT07284992
This study aims to evaluate the safety and preliminary efficacy of NALIRIFO...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2026-04
Trial ID
NCT07595172
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-13
Trial ID
NCT07645209
Treatments Being Tested
To evaluate the efficacy and safety of adebrelimab combined with chemoradio...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-13
Trial ID
NCT06478264
Treatments Being Tested